Skip to main content

Healy James's Form 4 filing

BioAge Labs, Inc. (BIOA) · filed Sep 27, 2024

Accession no.
0001415889-24-024044
Filed
Sep 27, 2024
Trade date
Sep 25-27, 2024
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market purchases total $12.0M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Healy JamesCIK 0001245624Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 27, 2024Common StockCConversionAcquired+1,638,236––1,638,236Indirect
Sep 27, 2024Common StockPPurchaseAcquired+588,888$18.00+$10,599,9842,227,124Indirect
Sep 27, 2024Common StockPPurchaseAcquired+11,113$18.00+$200,03411,113Indirect
Sep 27, 2024Common StockPPurchaseAcquired+18,353$18.00+$330,35418,353Indirect
Sep 27, 2024Common StockPPurchaseAcquired+21,814$18.00+$392,65221,814Indirect
Sep 27, 2024Common StockPPurchaseAcquired+26,497$18.00+$476,94626,497Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 25, 2024Common StockAGrant or awardAcquired+15,000$0.00$015,000Direct
Sep 27, 2024Common StockCConversionDisposed−1,638,236––0Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)